Back to Results
First PageMeta Content
IC50 / CLK1 / Dual-specificity kinase / Cell biology / Protein kinase / Cyclin-dependent kinase 1


Probe Report: An inhibitor of the Cdc2-like kinase 4 (Clk4)
Add to Reading List

Document Date: 2012-06-12 15:56:02

Open Document

File Size: 1,37 MB

Share Result on Facebook

City

Santa Clara / /

Company

ADP / Ambit Biosciences / Reaction Biology / Chronogen Inc. / Agilent Technologies / Sigma-Aldrich / Time of-Flight LC / Agilent LC / /

Country

United States / /

Currency

pence / /

Facility

National Cancer Institute / Medical Center Drive / National Human Genome Research Institute / Library Drive / /

Organization

National Cancer Institute / National Human Genome Research Institute / National Institute of Health / NIH Chemical Genomics Center / /

Person

David J. Maloneya / Craig J. Thomasa / Tom Misteli / Douglas S. Aulda / Tom Mistelib / Trung Nguyena / Min Shena / Christopher P.Austin / James M. Bougiea / Andrew S. Rosenthala / Bryan T. Motta / P. Austin Assay Submitter / /

Position

Methods General / /

ProvinceOrState

Maryland / /

Technology

Chemical Genomics / Assay protocol / optimized 1536-well protocol / Human Genome / /

URL

www.ambitbio.com / www.reactionbiology.com / /

SocialTag